Compare abrdn Income Credit Strategies Fund (ACP) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
abrdn Income Credit Strategies Fund vs Hims and Hers Health Inc — how do they compare? abrdn Income Credit Strategies Fund trades at $5.1 (market cap $641.16M), while Hims and Hers Health Inc trades at $29.94 (market cap $7.12B). The key difference: Hims and Hers Health Inc is far larger — about 11.1× abrdn Income Credit Strategies Fund's market cap, and abrdn Income Credit Strategies Fund pays a 18.2% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| ACP | HIMS | |
|---|---|---|
Market Cap | $641.16M | $7.12B |
Sector | Financials | Health |
52-Week High | $5.98 | $62.76 |
52-Week Low | $5.01 | $14.52 |
Dividend Yield | 18.2% | — |
Enterprise Value | — | $7.82B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACP trades at $5.15 with a 1.38% daily gain, showing neutral technical signals with bearish moving averages. The stock maintains strong profitability with a 95.31% net income margin and attractive valuation at 7.74 P/E ratio. Recent dividend declarations of $0.08 per share demonstrate income focus, though revenue declined from $79M in 2024 to $42M in 2025 before projected recovery to $85M in 2026.
ACP presents a mixed outlook with sustainable dividends and undervalued metrics offset by revenue volatility and high leverage concerns. The 17% distribution rate faces sustainability questions with only 49% supported by net investment income. Investors should weigh the attractive yield against credit spread risks and global exposure in this high-beta closed-end fund.
HIMS stock trades at $29.97, down 5.67% amid mixed Q2 2026 results. Revenue growth remains strong with a 2026 outlook raised to $3.1B-$3.3B, but profitability is pressured by margin compression and a net loss. Technical indicators are neutral to bearish, with support near $29. Recent news highlights an FTC investigation and class-action lawsuits adding uncertainty.
The outlook is cautious. Growth prospects from AI and global expansion are offset by significant margin challenges and regulatory risks. Analyst consensus is a Hold with a $33 price target, suggesting limited near-term upside amid execution and profitability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.
Read more on ACP →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
